"The major barrier to successful adherence and retention in care in poor regions is largely structural and economical,” as experienced with Real-time adherence and the Wisepill device in patients taking antiretroviral therapy (ART) in rural Uganda. Dr. Jessica Haberer, who’s been working on that project and on wireless technology for ART adherence monitoring for several years, shared practical insights on the roll-out of this technology in the GHDonline community.)
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
« StartPrev12NextEnd » |
||||||||||||||||||||||||||
| Page 1 of 2 | ||||||||||||||||||||||||||





